NanoViricides, Inc.
NNVC
$1.08
-$0.01-0.92%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 803.60K | 938.20K | 966.90K | 902.70K | 1.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.80M | 2.12M | 2.25M | 2.06M | 3.17M |
| Operating Income | -1.80M | -2.12M | -2.25M | -2.06M | -3.17M |
| Income Before Tax | -1.79M | -2.10M | -2.22M | -2.03M | -3.13M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.79M | -2.10M | -2.22M | -2.03M | -3.13M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.79M | -2.10M | -2.22M | -2.03M | -3.13M |
| EBIT | -1.80M | -2.12M | -2.25M | -2.06M | -3.17M |
| EBITDA | -1.66M | -1.95M | -2.06M | -1.86M | -2.97M |
| EPS Basic | -0.10 | -0.13 | -0.14 | -0.14 | -0.23 |
| Normalized Basic EPS | -0.07 | -0.08 | -0.09 | -0.09 | -0.14 |
| EPS Diluted | -0.10 | -0.13 | -0.14 | -0.14 | -0.23 |
| Normalized Diluted EPS | -0.07 | -0.08 | -0.09 | -0.09 | -0.14 |
| Average Basic Shares Outstanding | 17.08M | 16.18M | 16.03M | 14.57M | 13.72M |
| Average Diluted Shares Outstanding | 17.08M | 16.18M | 16.03M | 14.57M | 13.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |